EMPLOYMENT AGREEMENTEmployment Agreement • March 18th, 2015 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations • Colorado
Contract Type FiledMarch 18th, 2015 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (this “Agreement”), effective as of January 1st, 2015, is between N30 Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Jon Congleton (“Employee”).
AMENDMENT to the EMPLOYMENT AGREEMENT Effective November 1, 2012 between Nivalis Therapeutics, Inc. (formerly known as N30 Pharmaceuticals, Inc.) and Sherif E. Gabriel (“Employee”)Employment Agreement • March 18th, 2015 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 18th, 2015 Company IndustryWHEREAS, Nivalis Therapeutics, Inc. (formerly known as N30 Pharmaceuticals, Inc. (“Company”)) and the Employee entered into an employment agreement (the “Agreement”) effective as of November 1, 2012;
EMPLOYMENT AGREEMENTEmployment Agreement • March 18th, 2015 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations • Colorado
Contract Type FiledMarch 18th, 2015 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (this “Agreement”), effective as of November 1, 2012, is between N30 Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Sherif E. Gabriel (“Employee”).
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • March 18th, 2015 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations • Colorado
Contract Type FiledMarch 18th, 2015 Company Industry JurisdictionThis Amendment to Employment Agreement (this “Amendment”) is made and entered into as of December 15, 2014 by and between N30 Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Sherif Gabriel (“Employee”) and amends that certain Employment Agreement between the Company and Employee dated November 1, 2012 (the “Employment Agreement”).
AMENDMENT to the EMPLOYMENT AGREEMENT between Nivalis Therapeutics, Inc. (formerly known as N30 Pharmaceuticals, Inc.) and Jon Congleton (“Employee”)Employment Agreement • March 18th, 2015 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 18th, 2015 Company IndustryWHEREAS, Nivalis Therapeutics, Inc. (formerly known as N30 Pharmaceuticals, Inc. (the “Company”)) and the Employee entered into an employment agreement (the “Agreement”) effective as of January 1, 2015;
EMPLOYMENT AGREEMENTEmployment Agreement • March 18th, 2015 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations • Colorado
Contract Type FiledMarch 18th, 2015 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (this “Agreement”), effective as of August 7, 2013, is between N30 Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Charles H. Scoggin (“Employee”).
SECOND AMENDMENT TO LEASELease • March 18th, 2015 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 18th, 2015 Company IndustryTHIS SECOND AMENDMENT TO LEASE (this “Amendment”) is made effective as of the Eleventh day of February, 2015, by and between AWEIDA PROPERTIES, INC., a Colorado corporation (“Landlord”), and N30 PHARMACEUTICALS, INC. a Delaware Corporation (formerly, and identified in the Lease as, a Delaware Limited Liability Company) (“Tenant”) to that certain lease dated March 11, 2010 by and between Landlord and Tenant (the “Lease”), as amended by that certain First Amendment to Lease dated December 5, 2014, for the lease of Premises located at 3122 Sterling Circle, Suite 200, Boulder, Colorado 80301. Capitalized terms used herein which are defined in the Lease shall have the meanings therein stated.